Fierce Biotech (Washington DC) Thursday 15th September 2022
”Proteomics in drug development “ ”Incomplete knowledge of real-time biology underlying disease and drug action can drive up costs and time in drug development.Proteomic markers, along with other omics markers, can be used to predict response,stratify patient populations, and provide insight into the biology of disease.
Key applications to address the major challenges of drug development:- Escalating costs and increasing demands from regulatory authorities for a more precision medicine- based approach to drug development are substantial challenges for the pharmaceutical industry. Fast drug discovery with increased probability of successful implementation of new therapies can be greatly facilitated by multiomics approaches that can enable deep knowledge of the biologies underlying human disease and provide actionable insights to accelerate key decision making. Proteomics is now taking center stage in these approaches”
PIQ Price at posting:
$1.01 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)